Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: A review

Homocysteine, cysteine, and risk of incident colorectal cancer in the Women’;s Health Initiative observational cohort

(2013) Joshua W Miller et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

High homocysteine is associated with increased risk of colorectal cancer independently of oxidative stress and antioxidant capacities

(2013) Feng-Fan Chiang et al.   CLINICAL NUTRITION

Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability

(2013) Luciano Delgado-Plasencia et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Incidence and Mortality of Colorectal Adenocarcinoma in Persons With Inflammatory Bowel Disease From 1998 to 2010

(2012) Lisa J. Herrinton et al.   GASTROENTEROLOGY

Hyperhomocysteinemia is a risk factor for colorectal adenoma in women

(2012) Yun Jeong Lim et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Biomarkers of platelet activation in acute coronary syndromes

(2012) Patrizia Ferroni et al.   THROMBOSIS AND HAEMOSTASIS

Colorectal cancer in patients with inflammatory bowel disease: Can we predict risk?

(2012) Vibeke Andersen   WORLD JOURNAL OF GASTROENTEROLOGY

Etiology of inflammatory bowel disease: A unified hypothesis

(2012) Xiaofa Qin   WORLD JOURNAL OF GASTROENTEROLOGY

Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?

(2012) Jessica K Dyson   WORLD JOURNAL OF GASTROENTEROLOGY

Homocysteine Imbalance: a Pathological Metabolic Marker

(2012) Kevin L. Schalinske et al.   Advances in Nutrition

Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer

(2012) Deborah C. Rubin et al.   Frontiers in Immunology

Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases

(2011) A. Oussalah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress

(2011) Maureane Hoffman   MEDICAL HYPOTHESES

The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients

(2011) Magdalena Kedzierska et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Serum Folate and Homocysteine Levels Are Associated With Colon Tumorigenesis in End-Stage Renal Disease Patients

(2011) Eisuke Kaji et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Dysplasia and cancer in inflammatory bowel disease

(2011) Robert J Basseri et al.   Expert Review of Gastroenterology & Hepatology

Baseline Plasma Total Homocysteine and Adenoma Recurrence: Results from a Double Blind Randomized Clinical Trial of Aspirin and Folate Supplementation

(2010) A. J. Levine et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Serum Adiponectin, Leptin, C-Peptide, Homocysteine, and Colorectal Adenoma Recurrence in the Polyp Prevention Trial

(2010) G. Bobe et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Plasma Homocysteine and Cysteine and Risk of Breast Cancer in Women

(2010) J. Lin et al.   CANCER RESEARCH

Ursodeoxycholic acid and chemoprevention of colorectal cancer

(2010) L. Serfaty et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn's disease

(2010) Lamia Kallel et al.   Journal of Crohns & Colitis

Hyperhomocysteinemia and the role of B vitamins in cancer

(2010) Nadja Plazar et al.   Radiology and Oncology

Review article: diet and inflammatory bowel disease - epidemiology and treatment

(2009) T. YAMAMOTO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies

(2009) Elias Zintzaras   BIOMARKERS

Plasma Levels of B Vitamins and Colorectal Cancer Risk: The Multiethnic Cohort Study

(2009) L. Le Marchand et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease

(2009) Jeffrey Tang et al.   DIGESTIVE DISEASES AND SCIENCES

MHC Class II alleles in ulcerative colitis-associated colorectal cancer

(2009) M M Garrity-Park et al.   GUT

Inflammatory bowel disease: A survey of the epidemiology in Asia

(2009) KL GOH et al.   Journal of Digestive Diseases

Plasma Homocysteine, Folate, and Vitamin B12 Levels in Patients With Laryngeal Cancer

(2008) Andrea Nacci et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

One-Carbon Metabolism Biomarkers and Risk of Colon and Rectal Cancers

(2008) S. J. Weinstein et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Microsatellite Instability and the Association with Plasma Homocysteine and Thymidylate Synthase in Colorectal Cancer

(2008) Lars Henrik Jensen et al.   CANCER INVESTIGATION

Hyperhomocysteinemia in Inflammatory Bowel Disease Patients Without Past Intestinal Resections

(2008) Yusuf Erzin et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease

(2007) Jean Marc Phelip et al.   INFLAMMATORY BOWEL DISEASES